Medline Inc. (NASDAQ: MDLN) Stock Competitors & Peer Comparison
See MDLN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDLN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDLN | $38.75 | +2.98% | 32.8B | 45.06 | $0.86 | N/A |
| BDX | $156.36 | +2.22% | 56.6B | 11.62 | $13.45 | +2.39% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.39% |
| WST | $328.20 | -7.67% | 23.2B | 41.19 | $7.97 | +0.26% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| COO | $70.31 | +0.11% | 13.7B | 15.42 | $4.56 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.39% |
| BAX | $22.40 | +3.37% | 11.6B | 10.77 | $2.08 | +0.89% |
| ATR | $132.36 | +2.61% | 8.4B | 23.13 | $5.72 | +1.43% |
| AVTR | $11.44 | +0.79% | 7.8B | 13.46 | $0.85 | N/A |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDX)
MDLN vs BDX Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, BDX has a market cap of 56.6B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while BDX trades at $156.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas BDX's P/E ratio is 11.62. In terms of profitability, MDLN's ROE is +0.07%, compared to BDX's ROE of +0.05%. Regarding short-term risk, MDLN is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
MDLN vs BDXA Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas BDXA's P/E ratio is 45.70. In terms of profitability, MDLN's ROE is +0.07%, compared to BDXA's ROE of +0.05%. Regarding short-term risk, MDLN is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check BDXA's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
MDLN vs WST Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, WST has a market cap of 23.2B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while WST trades at $328.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas WST's P/E ratio is 41.19. In terms of profitability, MDLN's ROE is +0.07%, compared to WST's ROE of +0.19%. Regarding short-term risk, MDLN is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
MDLN vs HOLX Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas HOLX's P/E ratio is 31.54. In terms of profitability, MDLN's ROE is +0.07%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, MDLN is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HOLX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
MDLN vs COO Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, COO has a market cap of 13.7B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while COO trades at $70.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas COO's P/E ratio is 15.42. In terms of profitability, MDLN's ROE is +0.07%, compared to COO's ROE of +0.03%. Regarding short-term risk, MDLN is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check COO's competition here
Becton, Dickinson and Company (NYSE: BDXB)
MDLN vs BDXB Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas BDXB's P/E ratio is 7.60. In terms of profitability, MDLN's ROE is +0.07%, compared to BDXB's ROE of +0.05%. Regarding short-term risk, MDLN is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
MDLN vs BAX Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, BAX has a market cap of 11.6B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while BAX trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas BAX's P/E ratio is 10.77. In terms of profitability, MDLN's ROE is +0.07%, compared to BAX's ROE of -0.16%. Regarding short-term risk, MDLN is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BAX's competition here
AptarGroup, Inc. (NYSE: ATR)
MDLN vs ATR Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ATR trades at $132.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ATR's P/E ratio is 23.13. In terms of profitability, MDLN's ROE is +0.07%, compared to ATR's ROE of +0.14%. Regarding short-term risk, MDLN is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATR's competition here
Avantor, Inc. (NYSE: AVTR)
MDLN vs AVTR Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, AVTR has a market cap of 7.8B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while AVTR trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas AVTR's P/E ratio is 13.46. In terms of profitability, MDLN's ROE is +0.07%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, MDLN is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check AVTR's competition here
Repligen Corporation (NASDAQ: RGEN)
MDLN vs RGEN Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, RGEN has a market cap of 7.4B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while RGEN trades at $131.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas RGEN's P/E ratio is 73.31. In terms of profitability, MDLN's ROE is +0.07%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, MDLN is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check RGEN's competition here
Teleflex Incorporated (NYSE: TFX)
MDLN vs TFX Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while TFX trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas TFX's P/E ratio is 12.32. In terms of profitability, MDLN's ROE is +0.07%, compared to TFX's ROE of -0.28%. Regarding short-term risk, MDLN is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check TFX's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
MDLN vs BLCO Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, BLCO has a market cap of 5.8B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while BLCO trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas BLCO's P/E ratio is 24.88. In terms of profitability, MDLN's ROE is +0.07%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, MDLN is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
MDLN vs STVN Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while STVN trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas STVN's P/E ratio is 31.81. In terms of profitability, MDLN's ROE is +0.07%, compared to STVN's ROE of +0.10%. Regarding short-term risk, MDLN is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
MDLN vs MMSI Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, MMSI has a market cap of 4.4B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while MMSI trades at $74.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas MMSI's P/E ratio is 19.01. In terms of profitability, MDLN's ROE is +0.07%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, MDLN is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
MDLN vs ICUI Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ICUI trades at $157.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ICUI's P/E ratio is 19.66. In terms of profitability, MDLN's ROE is +0.07%, compared to ICUI's ROE of +0.02%. Regarding short-term risk, MDLN is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ICUI's competition here
Haemonetics Corporation (NYSE: HAE)
MDLN vs HAE Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while HAE trades at $78.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas HAE's P/E ratio is 15.86. In terms of profitability, MDLN's ROE is +0.07%, compared to HAE's ROE of +0.11%. Regarding short-term risk, MDLN is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HAE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
MDLN vs XRAY Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, XRAY has a market cap of 2.6B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while XRAY trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas XRAY's P/E ratio is 9.04. In terms of profitability, MDLN's ROE is +0.07%, compared to XRAY's ROE of -0.41%. Regarding short-term risk, MDLN is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
MDLN vs LMAT Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, LMAT has a market cap of 2.2B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while LMAT trades at $95.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas LMAT's P/E ratio is 37.05. In terms of profitability, MDLN's ROE is +0.07%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, MDLN is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check LMAT's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
MDLN vs PLSE Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, PLSE has a market cap of 2.1B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while PLSE trades at $30.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas PLSE's P/E ratio is -27.48. In terms of profitability, MDLN's ROE is +0.07%, compared to PLSE's ROE of -0.87%. Regarding short-term risk, MDLN is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
MDLN vs ATRC Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ATRC has a market cap of 1.8B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ATRC trades at $35.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ATRC's P/E ratio is 1088.20. In terms of profitability, MDLN's ROE is +0.07%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, MDLN is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
MDLN vs BLFS Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, BLFS has a market cap of 1.5B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while BLFS trades at $29.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas BLFS's P/E ratio is -141.85. In terms of profitability, MDLN's ROE is +0.07%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, MDLN is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
MDLN vs AZTA Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, AZTA has a market cap of 1.3B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while AZTA trades at $27.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas AZTA's P/E ratio is 60.82. In terms of profitability, MDLN's ROE is +0.07%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, MDLN is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
MDLN vs KMTS Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, KMTS has a market cap of 1.2B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while KMTS trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas KMTS's P/E ratio is -8.92. In terms of profitability, MDLN's ROE is +0.07%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, MDLN is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
MDLN vs STAA Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while STAA trades at $23.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas STAA's P/E ratio is 41.02. In terms of profitability, MDLN's ROE is +0.07%, compared to STAA's ROE of -0.06%. Regarding short-term risk, MDLN is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
MDLN vs QDEL Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, QDEL has a market cap of 1.1B. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while QDEL trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas QDEL's P/E ratio is 11.98. In terms of profitability, MDLN's ROE is +0.07%, compared to QDEL's ROE of -0.56%. Regarding short-term risk, MDLN is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
MDLN vs ATRI Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ATRI's P/E ratio is 64.50. In terms of profitability, MDLN's ROE is +0.07%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, MDLN is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
MDLN vs ANGO Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ANGO has a market cap of 561.7M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ANGO trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ANGO's P/E ratio is -34.85. In terms of profitability, MDLN's ROE is +0.07%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, MDLN is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
MDLN vs NNNN Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, NNNN has a market cap of 441.5M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while NNNN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas NNNN's P/E ratio is 145.38. In terms of profitability, MDLN's ROE is +0.07%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, MDLN is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
MDLN vs OSUR Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, OSUR has a market cap of 273.3M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while OSUR trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas OSUR's P/E ratio is -4.78. In terms of profitability, MDLN's ROE is +0.07%, compared to OSUR's ROE of -0.21%. Regarding short-term risk, MDLN is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check OSUR's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
MDLN vs SMTI Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, SMTI has a market cap of 234.2M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while SMTI trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas SMTI's P/E ratio is -426.00. In terms of profitability, MDLN's ROE is +0.07%, compared to SMTI's ROE of -2.46%. Regarding short-term risk, MDLN is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check SMTI's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
MDLN vs UTMD Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, UTMD has a market cap of 213.8M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while UTMD trades at $67.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas UTMD's P/E ratio is 19.86. In terms of profitability, MDLN's ROE is +0.07%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, MDLN is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check UTMD's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
MDLN vs INFU Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, INFU has a market cap of 183.9M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while INFU trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas INFU's P/E ratio is 23.97. In terms of profitability, MDLN's ROE is +0.07%, compared to INFU's ROE of +0.14%. Regarding short-term risk, MDLN is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check INFU's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
MDLN vs KRMD Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, KRMD has a market cap of 175.9M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while KRMD trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas KRMD's P/E ratio is -95.75. In terms of profitability, MDLN's ROE is +0.07%, compared to KRMD's ROE of -0.14%. Regarding short-term risk, MDLN is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check KRMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
MDLN vs PDEX Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, PDEX has a market cap of 175.4M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while PDEX trades at $54.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas PDEX's P/E ratio is 19.34. In terms of profitability, MDLN's ROE is +0.07%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, MDLN is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check PDEX's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
MDLN vs MBOT Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, MBOT has a market cap of 77.9M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while MBOT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas MBOT's P/E ratio is -6.58. In terms of profitability, MDLN's ROE is +0.07%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, MDLN is more volatile compared to MBOT. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
MDLN vs AKYA Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas AKYA's P/E ratio is -1.34. In terms of profitability, MDLN's ROE is +0.07%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, MDLN is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
MDLN vs STSS Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, STSS has a market cap of 58.4M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while STSS trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas STSS's P/E ratio is -0.02. In terms of profitability, MDLN's ROE is +0.07%, compared to STSS's ROE of -1.66%. Regarding short-term risk, MDLN is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check STSS's competition here
Daxor Corporation (NASDAQ: DXR)
MDLN vs DXR Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, DXR has a market cap of 52.7M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while DXR trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas DXR's P/E ratio is 27.33. In terms of profitability, MDLN's ROE is +0.07%, compared to DXR's ROE of +0.22%. Regarding short-term risk, MDLN is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check DXR's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
MDLN vs OMIC Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas OMIC's P/E ratio is -0.58. In terms of profitability, MDLN's ROE is +0.07%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, MDLN is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
MDLN vs IGAP Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas IGAP's P/E ratio is -10.52. In terms of profitability, MDLN's ROE is +0.07%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, MDLN is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
MDLN vs NEPH Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, NEPH has a market cap of 38.6M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while NEPH trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas NEPH's P/E ratio is 50.86. In terms of profitability, MDLN's ROE is +0.07%, compared to NEPH's ROE of +0.08%. Regarding short-term risk, MDLN is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NEPH's competition here
Milestone Scientific Inc. (AMEX: MLSS)
MDLN vs MLSS Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, MLSS has a market cap of 34.5M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while MLSS trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas MLSS's P/E ratio is -6.50. In terms of profitability, MDLN's ROE is +0.07%, compared to MLSS's ROE of -1.66%. Regarding short-term risk, MDLN is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check MLSS's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
MDLN vs POCI Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, POCI has a market cap of 33.8M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while POCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas POCI's P/E ratio is -6.07. In terms of profitability, MDLN's ROE is +0.07%, compared to POCI's ROE of -0.37%. Regarding short-term risk, MDLN is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check POCI's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
MDLN vs SDC Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas SDC's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.07%, compared to SDC's ROE of -1.96%. Regarding short-term risk, MDLN is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check SDC's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
MDLN vs HBIO Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, HBIO has a market cap of 27.3M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while HBIO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas HBIO's P/E ratio is -16.81. In terms of profitability, MDLN's ROE is +0.07%, compared to HBIO's ROE of -0.73%. Regarding short-term risk, MDLN is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HBIO's competition here
Invacare Corporation (NYSE: IVC)
MDLN vs IVC Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas IVC's P/E ratio is -0.79. In terms of profitability, MDLN's ROE is +0.07%, compared to IVC's ROE of -0.46%. Regarding short-term risk, MDLN is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
MDLN vs RVP Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while RVP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas RVP's P/E ratio is -2.06. In terms of profitability, MDLN's ROE is +0.07%, compared to RVP's ROE of -0.08%. Regarding short-term risk, MDLN is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check RVP's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
MDLN vs ZJYL Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ZJYL has a market cap of 16M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ZJYL trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ZJYL's P/E ratio is 12.75. In terms of profitability, MDLN's ROE is +0.07%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, MDLN is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check ZJYL's competition here
Femasys Inc. (NASDAQ: FEMY)
MDLN vs FEMY Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, FEMY has a market cap of 11.2M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while FEMY trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas FEMY's P/E ratio is -10.25. In terms of profitability, MDLN's ROE is +0.07%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, MDLN is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
MDLN vs RGNT Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, RGNT has a market cap of 7.8M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while RGNT trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas RGNT's P/E ratio is -0.08. In terms of profitability, MDLN's ROE is +0.07%, compared to RGNT's ROE of N/A. Regarding short-term risk, MDLN is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check RGNT's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
MDLN vs NSTG Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas NSTG's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.07%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, MDLN is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
MDLN vs NXGL Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, NXGL has a market cap of 4M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while NXGL trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas NXGL's P/E ratio is -1.13. In terms of profitability, MDLN's ROE is +0.07%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, MDLN is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check NXGL's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
MDLN vs POAI Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas POAI's P/E ratio is -0.03. In terms of profitability, MDLN's ROE is +0.07%, compared to POAI's ROE of -107.05%. Regarding short-term risk, MDLN is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check POAI's competition here
Lucyd, Inc (NASDAQ: LUCY)
MDLN vs LUCY Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, LUCY has a market cap of 2.6M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while LUCY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas LUCY's P/E ratio is -0.39. In terms of profitability, MDLN's ROE is +0.07%, compared to LUCY's ROE of -0.83%. Regarding short-term risk, MDLN is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check LUCY's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
MDLN vs MHUA Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas MHUA's P/E ratio is 0.25. In terms of profitability, MDLN's ROE is +0.07%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, MDLN is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
MDLN vs NXGLW Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, NXGLW has a market cap of 1.8M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas NXGLW's P/E ratio is -0.06. In terms of profitability, MDLN's ROE is +0.07%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, MDLN is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check NXGLW's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
MDLN vs GMVD Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas GMVD's P/E ratio is -0.01. In terms of profitability, MDLN's ROE is +0.07%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, MDLN is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
MDLN vs GMVDW Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas GMVDW's P/E ratio is N/A. In terms of profitability, MDLN's ROE is +0.07%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, MDLN is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
MDLN vs AVGR Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas AVGR's P/E ratio is -0.05. In terms of profitability, MDLN's ROE is +0.07%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, MDLN is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
MDLN vs LUCYW Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas LUCYW's P/E ratio is -0.00. In terms of profitability, MDLN's ROE is +0.07%, compared to LUCYW's ROE of -0.83%. Regarding short-term risk, MDLN is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check LUCYW's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
MDLN vs GCTK Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, GCTK has a market cap of 165.2K. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while GCTK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas GCTK's P/E ratio is -0.01. In terms of profitability, MDLN's ROE is +0.07%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, MDLN is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for MDLN.Check GCTK's competition here
Invuity, Inc. (NASDAQ: IVTY)
MDLN vs IVTY Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas IVTY's P/E ratio is -3.80. In terms of profitability, MDLN's ROE is +0.07%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, MDLN is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IVTY's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
MDLN vs ATRS Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ATRS's P/E ratio is 14.95. In terms of profitability, MDLN's ROE is +0.07%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, MDLN is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ATRS's competition here
Apria, Inc. (NASDAQ: APR)
MDLN vs APR Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, APR has a market cap of 0. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas APR's P/E ratio is 22.59. In terms of profitability, MDLN's ROE is +0.07%, compared to APR's ROE of +9.81%. Regarding short-term risk, MDLN is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
MDLN vs IIN Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, IIN has a market cap of 0. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas IIN's P/E ratio is 226.45. In terms of profitability, MDLN's ROE is +0.07%, compared to IIN's ROE of -0.00%. Regarding short-term risk, MDLN is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check IIN's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
MDLN vs HRC Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, HRC has a market cap of 0. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas HRC's P/E ratio is 41.92. In terms of profitability, MDLN's ROE is +0.07%, compared to HRC's ROE of +0.14%. Regarding short-term risk, MDLN is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check HRC's competition here
Analogic Corporation (NASDAQ: ALOG)
MDLN vs ALOG Comparison July 2026
Medline Inc. (NASDAQ: MDLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLN stands at 32.8B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, MDLN is priced at $38.75 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLN currently has a P/E ratio of 45.06, whereas ALOG's P/E ratio is 40.93. In terms of profitability, MDLN's ROE is +0.07%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, MDLN is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for MDLN.Check ALOG's competition here